Cutler Group LP Nrx Pharmaceuticals, Inc. Put Options Transaction History
Cutler Group LP
- $307 Million
- Q1 2024
Put Options
2 transactions
Others Institutions Holding NRXP
# of Institutions
2Shares Held
17.4KCall Options Held
0Put Options Held
0About NRX Pharmaceuticals, Inc.
- Ticker NRXP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 67,641,296
- Market Cap $87.3M
- Description
- NRX Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, develops novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. Its products include ZYESAMI, an investigational drug that has completed a Phase IIb/III clinical study for COVID-19 related respiratory failure; and NRX-10...